Search

everythinglearnresearchcommunity

for

Search:↓

Current research on seborrheic dermatitis highlights key focus areas and suggests future study directions.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

SHED-CM can reduce hair graying and protect against damage from X-rays.

Microneedling improves skin and hair conditions by enhancing treatment absorption and stimulating growth factors.

Sunlight exposure damages hair follicles, but certain stem cell-derived particles can reduce this damage and help with hair regeneration.

CBD is effective for certain epilepsy conditions, shows promise for other health issues, but needs more research for safety and effectiveness.

Multivitamin gummies with various vitamins and minerals offer a tasty and easy-to-digest alternative to traditional supplements.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Eclipta prostrata has many medicinal benefits, but more research is needed to understand how it works.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Combining Datura metel leaf and flower extracts can enhance hair growth without skin irritation.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

People with Down syndrome often have skin issues and need regular check-ups for early treatment.

Homeopathy can safely help regrow hair and improve well-being in alopecia areata.

Gold nanoparticles show promise for treating inflammatory bowel disease by reducing inflammation and colon injury.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.